Internal Medicine, Gastroenterology · Staten Island, NY
NPI
1235119660
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
360 Edison St
Staten Island, NY, 10306
Phone (718) 351-6277
Groups this clinician bills Medicare through
Medicare paid, 2024
$433K
2,876 services
Medicare patients, 2024
834
Average age 74
Drug cost, 2024
$339K
5,142 prescriptions
Company payments, 2025
$2,062
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Megna was code 99213 (office e&m - established), 1,806 times for 810 patients. In total Daniel Megna billed 2,876 services in 14 codes, and Medicare paid $433K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,806 | 810 | $72.54 | $131K |
| 43239 Upper GI Endoscopy | Office | 514 | 507 | $328.37 | $169K |
| 45385 Colonoscopy - Lesion Removal | Office | 214 | 214 | $395.30 | $85K |
| 45381 Lower GI Endoscopy - Other | Office | 194 | 194 | $92.71 | $18K |
| 45380 Lower GI Endoscopy - Other | Office | 57 | 57 | $386.09 | $22K |
| 99202 Office E&M - New | Office | 57 | 57 | $58.21 | $3,318 |
| 43450 Digestive/Gastrointestinal | Office | 13 | 12 | $78.82 | $1,025 |
By year: 2022 $552K for 3,835 services; 2023 $515K for 3,323 services; 2024 $433K for 2,876 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Megna prescribed most often to Medicare patients was Famotidine, with 2,075 prescriptions and refills. In total Daniel Megna wrote 5,142 Medicare prescriptions that cost $339K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 2,075 | 5,883 | 691 | $42K |
| Pantoprazole Sodium Generic | 787 | 2,261 | 266 | $9,990 |
| Omeprazole Generic | 444 | 1,243 | 155 | $6,961 |
| Lansoprazole Generic | 433 | 1,250 | 145 | $12K |
| Dicyclomine Hcl Generic | 177 | 315 | 69 | $3,777 |
| Esomeprazole Magnesium Generic | 89 | 228 | 32 | $2,683 |
| Sucralfate Generic | 88 | 167 | 29 | $1,704 |
| Alprazolam Generic | 76 | 76 | 17 | $749 |
| Ciprofloxacin Hcl Generic | 55 | 55 | 38 | $556 |
| Hydrocortisone Generic | 46 | 48 | 22 | $572 |
| Mesalamine Generic | 45 | 111 | 12 | $24K |
| Linzess Linaclotide | 42 | 78 | 14 | $39K |
| Dexlansoprazole Dr Dexlansoprazole | 37 | 89 | Under 11 | $12K |
| Prochlorperazine Maleate Generic | 32 | 36 | 13 | $840 |
| Metronidazole Generic | 26 | 26 | 23 | $805 |
Brand drugs: 186 claims; generic drugs: 4,956 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Megna $2,062 ($2,062 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $356.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $356 |
| Janssen Biotech, Inc. JNJ | 13 | $347 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $268 |
| Olympus America Inc. | 4 | $182 |
| Ardelyx, Inc. ARDX | 7 | $176 |
| Lilly USA, LLC LLY | 9 | $146 |
| Genzyme Corporation SNY | 4 | $93.18 |
| Madrigal Pharmaceuticals MDGL | 5 | $92.67 |
| Phathom Pharmaceuticals, Inc. PHAT | 10 | $80.96 |
| Pfizer Inc. PFE | 4 | $73.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.